Hillsborough, CA, United States of America

David V Goeddel

Average Co-Inventor Count = 2.3

ph-index = 28

Forward Citations = 1,845(Granted Patents)

Forward Citations (Not Self Cited) = 1,753(Sep 21, 2024)

DiyaCoin DiyaCoin 1.03 

Inventors with similar research interests:


Location History:

  • Hillsburough, CA (US) (1993)
  • Forestview, CA (US) (1994)
  • South San Francisco, CA (US) (1996)
  • Hillborough, CA (US) (1998)
  • Burlingame, CA (US) (1982 - 2003)
  • Hillsborough, CA (US) (1988 - 2010)


Years Active: 1982-2010

where 'Filed Patents' based on already Granted Patents

92 patents (USPTO):
1 patent (CIPO):

Title: Pioneering the Biopharmaceutical Industry: The Innovations of David V Goeddel

Introduction: David V Goeddel, a renowned inventor in the field of biopharmaceuticals, hailing from Hillsborough, CA, has made significant contributions with an impressive portfolio of 92 patents.

Latest Patents:

1. Antibodies to tumor necrosis factor receptor associated factor polypeptides: Goeddel's groundbreaking invention introduces antibodies to novel tumor necrosis factor receptor associated factors (TRAF), which play a crucial role in mediating tumor necrosis factor (TNF) biological activities.

2. Regulators of apoptosis: His innovation focuses on apoptosis regulating proteins, specifically Casper proteins, offering methods and compositions for their production from transformed host cells or purification from human cells. This invention opens new avenues in diagnosis, therapy, and the biopharmaceutical industry.

Career Highlights: Goeddel's expertise has been honed through his tenure at esteemed companies such as Genentech, Inc. and Tularik Limited, where he has made significant strides in the biopharmaceutical sector.

Collaborations: Throughout his career, Goeddel has collaborated with notable peers such as William J Kohr and Diane Pennica, collectively driving innovation and excellence in the field of biopharmaceuticals.

Conclusion: David V Goeddel's prolific career and groundbreaking inventions stand as a testament to his enduring legacy in the realm of biopharmaceutical innovations, shaping the future of medicine and healthcare with his unparalleled contributions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…